Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
March 13, 2024Journal of the American Chemical Society

A Programmable Peptidic Hydrogel Adjuvant for Personalized Immunotherapy in Resected Stage Tumors

View Full Paper
Ask AI
Bookmark
Share

Authors

BWBihan WuJLJuan LiangXYXuejiao Yang

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Wu et al. (2024) studied this question.

synapsesocial.com/papers/68e74210b6db6435876bbfcfhttps://doi.org/10.1021/jacs.4c00569
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1A <scp>GSH</scp>‐Responsive Immune‐Stimulating Polypeptide Hydrogel Loaded with Chemotherapeutics, <scp>IDO</scp> Inhibitor and Immune Checkpoint Blocking Antibody for Enhanced Anti‐Tumor Chemo‐Immunotherapy2024 · 10 citations
  2. 2Syringeable Near-Infrared Light-Activated In Situ Immunogenic Hydrogel Boosts the Cancer-Immunity Cycle to Enhance Anticancer Immunity2024 · 36 citations
  3. 3Self‐Adjuvanting Bacteria Hydrogel for SHP1 Checkpoint Inhibition in Tumor‐Draining Lymph Nodes to Enhance Cancer Immunotherapy2024 · 3 citations
  4. 4Personalized Vaccination of Tumor‐Derived Antigens and STING Agonists for Specific Cancer Immunotherapy2025 · 9 citations
  5. 5Remote‐Controllable Immune‐Priming Spot Formation Via Nanocomplexed Hydrogel‐Assisted Histotripsy: <i>Immunoasis</i>2025